Ford JM - Search Results

1

Practical management of patients with chronic myeloid leukemia receiving imatinib.

Deininger MW, O'Brien SG, Ford JM, Druker BJ. Deininger MW, et al. Among authors: ford jm. J Clin Oncol. 2003 Apr 15;21(8):1637-47. doi: 10.1200/JCO.2003.11.143. Epub 2003 Mar 13. J Clin Oncol. 2003. PMID: 12668652 Review.

2

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.

Peng B, Hayes M, Resta D, Racine-Poon A, Druker BJ, Talpaz M, Sawyers CL, Rosamilia M, Ford J, Lloyd P, Capdeville R. Peng B, et al. J Clin Oncol. 2004 Mar 1;22(5):935-42. doi: 10.1200/JCO.2004.03.050. J Clin Oncol. 2004. PMID: 14990650 Clinical Trial.

3

Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571).

Leis JF, Stepan DE, Curtin PT, Ford JM, Peng B, Schubach S, Druker BJ, Maziarz RT. Leis JF, et al. Among authors: ford jm. Leuk Lymphoma. 2004 Apr;45(4):695-8. doi: 10.1080/10428190310001625728. Leuk Lymphoma. 2004. PMID: 15160941 Clinical Trial.

4

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL. Druker BJ, et al. Among authors: ford jm. N Engl J Med. 2001 Apr 5;344(14):1031-7. doi: 10.1056/NEJM200104053441401. N Engl J Med. 2001. PMID: 11287972 Free article. Clinical Trial.

5

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. Druker BJ, et al. Among authors: ford jm. N Engl J Med. 2001 Apr 5;344(14):1038-42. doi: 10.1056/NEJM200104053441402. N Engl J Med. 2001. PMID: 11287973 Free article. Clinical Trial.

6

Chronic myelogenous leukemia.

Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM. Druker BJ, et al. Among authors: ford jm. Hematology Am Soc Hematol Educ Program. 2001:87-112. doi: 10.1182/asheducation-2001.1.87. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722980 Review.

7

Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.

Capdeville R, Krahnke T, Hatfield A, Ford JM, Van Hoomissen I, Gathmann I. Capdeville R, et al. Among authors: ford jm. Ann Oncol. 2008 Jul;19(7):1320-1326. doi: 10.1093/annonc/mdn050. Epub 2008 Mar 15. Ann Oncol. 2008. PMID: 18344535 Free article.

8

Cerebral oedema as a possible complication of treatment with imatinib.

Ebnöether M, Stentoft J, Ford J, Buhl L, Gratwohl A. Ebnöether M, et al. Lancet. 2002 May 18;359(9319):1751-2. doi: 10.1016/S0140-6736(02)08616-6. Lancet. 2002. PMID: 12049868

9

Imatinib treatment: specific issues related to safety, fertility, and pregnancy.

Hensley ML, Ford JM. Hensley ML, et al. Among authors: ford jm. Semin Hematol. 2003 Apr;40(2 Suppl 2):21-5. doi: 10.1053/shem.2003.50038. Semin Hematol. 2003. PMID: 12783371 Review.

10

Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing.

Naghi LA, Culver JO, Ricker C, Sturgeon D, Kingham K, Hodan R, Chun NM, Kidd J, Bonner J, Hong C, Morales-Pichardo J, Mills M, Lindsey S, McDonnell K, Ladabaum U, Ford JM, Gruber SB, Kurian AW, Idos GE. Naghi LA, et al. Among authors: ford jm. JAMA Netw Open. 2025 Jan 2;8(1):e2454447. doi: 10.1001/jamanetworkopen.2024.54447. JAMA Netw Open. 2025. PMID: 39804645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters